Immunocore Competitors and Similar CompaniesClear all
Immunocore's competitors and similar companies include LogicBio Therapeutics and Sutro Biopharma.
 Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. |  LogicBio Therapeutics LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment. | ||
Founding Date | Founding Date 2008 | Founding Date 2014 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Milton, GB HQ Conshohocken, US Rockville, US | Locations Lexington, US HQ Louisville, US | Locations South San Francisco, US HQ |
Employees | Employees 493 | Employees 4178% increase | Employees 3029% increase |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 176.3 m | Valuation ($) 294.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $400m (FY, 2025) | Revenue (est.) $5.4m (FY, 2021) | Revenue (est.) $102.5m (FY, 2025) |
Net income | Net income ($35.5m) (FY, 2025) | Net income ($40m) (FY, 2021) | Net income ($191.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 565m | Total funding raised $ 49m | Total funding raised $ 201.7m |
For sources of this data, please see the company profile
View Company Profiles
LogicBio Therapeutics
HQ
Lexington, US
Employees
41
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
View company
Sutro Biopharma
HQ
South San Francisco, US
Employees
302↑ 9% increase
Sutro Biopharma is a clinical-stage company that develops cancer therapeutics.
View company